Acquired Resistance to Osimertinib Plus Savolitinib Is Mediated by MET-D1228 and MET-Y1230 Mutations in EGFR-Mutated MET-Amplified Lung Cancer

Saved in:
Bibliographic Details
Published in:JTO clinical and research reports 2020, Vol.1 (4), p.100071-100071
Main Authors: Piper-Vallillo, Andrew J, Halbert, Brian T, Rangachari, Deepa, Kobayashi, Susumu S, Costa, Daniel B
Format: Report
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2666-3643
DOI:10.1016/j.jtocrr.2020.100071